A Short-Course Therapy of Complicated UTI, Pyelonephritis Cleared
The FDA has approved the use of a five-day, once-daily regimen of Levaquin (levofloxacin) 750 mg IV and oral for the treatment of complicated UTI and acute pyelonephritis (AP).
The FDA has approved the use of a five-day, once-daily regimen of Levaquin (levofloxacin) 750 mg IV and oral for the treatment of complicated UTI and acute pyelonephritis (AP).
CHICAGO—An international survey of uropathogens isolated from women with uncomplicated UTIs suggests that physicians may need to rethink the antibiotics they use for empiric treatment.
Proteus bacteriuria may be a marker for poor urinary health in spinal-cord injury (SCI) patients.
TORONTO—Guidelines are needed for managing positive urine cultures in the ICU because clinicians often prescribe antibiotics inappropriately, researchers reported here at the annual meeting of the Infectious Diseases Society of America.
SAN FRANCISCO—Urinary schistosomiasis is a common infection in sub-Saharan Africa and the Mideast, and more cases could surface in the United States because of greater international travel and immigration from those regions, according to an infectious disease specialist.
SAN FRANCISCO—Genitourinary tuberculosis (GUTB) cases are on the rise in the United States and globally, but they often are difficult to diagnose, leading to a delay in dialysis that can worsen renal damage, according to a Turkish researcher.
TORONTO—Enterococcus has emerged as the predominant pathogen associated with symptomatic UTIs in the first six months after renal transplantation, data show.
TORONTO—By examining temporal patterns of Escherichia coli colonization of the periurethra and urine, it may soon be possible to intervene and prevent recurrent UTIs in an unprecedented way.
TORONTO—Pyuria may not be an accurate indicator of UTI in patients presenting with acute urolithiasis, California researchers report.